CCM
PFE icon

CFO Capital Management’s Pfizer PFE Stock Holding History

CFO Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$441K Sell
15,696
-2,524
-14% -$67.2K 0.36% 74
2025
Q4 		$454K Buy
+18,220
New +$459K 0.34% 74

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

CFO Capital Management's PFE Position: Q1 2026 in Review

CFO Capital Management reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $67.2K and leaving 15,696 shares worth $441K. The position accounts for 0.36% of the portfolio, ranked #74.

CFO Capital Management first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. The position peaked at $454K in Q4 2025. 2,949 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CFO Capital Management held 15,696 shares of Pfizer worth $441K as of Q1 2026.
  • CFO Capital Management sold 2,524 Pfizer shares in Q1 2026, an estimated $67.2K.
  • Pfizer made up 0.36% of CFO Capital Management's portfolio in Q1 2026, its #74 holding.
  • CFO Capital Management first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
  • CFO Capital Management's Pfizer position peaked at $454K in Q4 2025.
  • 2,949 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CFO Capital Management's 13F filing for Q1 2026, filed 4 May 2026.